Cargando…

Correction to: Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis

Detalles Bibliográficos
Autores principales:	Chen, Jun, Li, Wenjie, Liu, Binjie, Xie, Xiaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476286/ https://www.ncbi.nlm.nih.gov/pubmed/36104751 http://dx.doi.org/10.1186/s12903-022-02395-9

Ejemplares similares

Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis
por: Chen, Jun, et al.
Publicado: (2022)

Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition
por: Lin, Ching-Yeh, et al.
Publicado: (2019)

Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation
por: Karnam, Shyamala, et al.
Publicado: (2022)

LINC00312/YBX1 Axis Regulates Myofibroblast Activities in Oral Submucous Fibrosis
por: Yu, Chuan-Hang, et al.
Publicado: (2020)

Pathological investigations and correlation research of microfibrillar-associated protein 4 and tropoelastin in oral submucous fibrosis
por: Liu, Binjie, et al.
Publicado: (2021)

Research Achievements of Oral Submucous Fibrosis: Progress and Prospect
por: Xu, Hui, et al.
Publicado: (2021)

Oral submucous fibrosis: an update
por: Wollina, Uwe, et al.
Publicado: (2015)

Oral submucous fibrosis: An update
por: Ray, Jay Gopal, et al.
Publicado: (2017)

Long Non-Coding RNA Expression Profile Associated with Malignant Progression of Oral Submucous Fibrosis
por: Zhou, Shanghui, et al.
Publicado: (2019)

Drug treatment for oral submucous fibrosis: an update
por: Chen, Xueru, et al.
Publicado: (2023)

The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis
por: Chaudhary, Minal, et al.
Publicado: (2015)

Identification of a combined biomarker for malignant transformation in oral submucous fibrosis
por: Bazarsad, Shadavlonjid, et al.
Publicado: (2016)

Lipid profile in oral submucous fibrosis
por: Mehrotra, Ravi, et al.
Publicado: (2009)

Medical management of oral submucous fibrosis
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2015)

Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis
por: Jyothi Meka, Naga, et al.
Publicado: (2015)

The role of myofibroblasts in the progression of oral submucous fibrosis: A systematic review
por: Wadhwan, Vijay, et al.
Publicado: (2019)

Malignant potentiality assessment of oral submucous fibrosis through semi-quantitative approach
por: Pal, Mousumi, et al.
Publicado: (2020)

Oral Submucous Fibrosis: Etiological Mechanism, Malignant Transformation, Therapeutic Approaches and Targets
por: Qin, Xiaofeng, et al.
Publicado: (2023)

Management of Oral Submucous Fibrosis with Injection of Hyaluronidase and Dexamethasone in Grade III Oral Submucous Fibrosis: A Retrospective Study
por: James, Leena, et al.
Publicado: (2015)

Loss of oral mucosal stem cell markers in oral submucous fibrosis and their reactivation in malignant transformation
por: Sharma, Mohit, et al.
Publicado: (2020)

PTEN and α-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis
por: Monteiro, Roshni, et al.
Publicado: (2021)

Submucous fibrosis of the oral cavity. Histomorphological studies.
por: Wahi, P. N., et al.
Publicado: (1966)

Proliferation and apoptosis markers in oral submucous fibrosis
por: Ranganathan, K, et al.
Publicado: (2011)

Oral submucous fibrosis and its dermatological relation
por: Ali, Fareedi Mukram, et al.
Publicado: (2014)

Pathogenesis and therapeutic intervention of oral submucous fibrosis
por: Yoithapprabhunath, Thukanaykanpalayam Ragunathan, et al.
Publicado: (2013)

Immunohistochemical Analysis of Vimentin in Oral Submucous Fibrosis
por: Nayak, Meghanand T., et al.
Publicado: (2013)

Oral submucous fibrosis and plasma lipid profile
por: Pantvaidya, G. H., et al.
Publicado: (2013)

Oral submucous fibrosis: Are we doing enough?
por: Chugh, Ankita, et al.
Publicado: (2019)

Carcinoma Arising in the Background of Oral Submucous Fibrosis
por: Rangaswamy, Shruthi, et al.
Publicado: (2019)

Evaluation of Hematological Profile in Oral Submucous Fibrosis
por: Abidullah, Mohammed, et al.
Publicado: (2022)

Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis
por: Murthy, Vignesh, et al.
Publicado: (2022)

Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma—A Systematic Review and Meta-Analysis
por: Mohapatra, Diksha, et al.
Publicado: (2023)

Buccal fat pad reconstruction for oral submucous fibrosis
por: Surej, Kumar L. K., et al.
Publicado: (2010)

Ultrasonographic Evaluation of Oral Submucous Fibrosis and Masseteric Hypertrophy
por: Devathambi, Jones Raja, et al.
Publicado: (2013)

Prognostic potential of AgNORs in oral submucous fibrosis
por: Murgod, Sanjay, et al.
Publicado: (2016)

Areca nut and its role in oral submucous fibrosis
por: Prabhu, Rachana V., et al.
Publicado: (2014)

Plasma fibrinogen degradation products in oral submucous fibrosis
por: Gupta, Sonia, et al.
Publicado: (2015)

Evaluation of oxidative stress and the microenvironment in oral submucous fibrosis
por: Rai, Vertika, et al.
Publicado: (2019)

Effectiveness of Osteopathic Therapy in the Treatment of Oral Submucous Fibrosis
por: Goyal, Manu, et al.
Publicado: (2017)

Photobiomodulation therapy inhibits oral submucous fibrosis in mice
por: Chiang, Min‐Hsuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4jtupseh7ekah9aa222uj76iue